Fig. 4

The Kaplan-Meier survival curve for recurrence-free survival of thyroid cancer patients. The patients were divided into two groups, based on the median value of each signature of glucose metabolism. PTC patients with low glycolysis signature have significantly less recurrence than the other group (a, p = 0.045). PDTC/ATC patients with low glycolysis signature showed better prognosis (b, p = 0.015). GLUT signature showed no significant correlation with recurrence-free survival in PTC patients (c, p = 0.85). PDTC/ATC patients with low GLUT signature showed better prognosis (d, p = 0.0063)